Lucemyra To Treat Opioid Withdrawal

Lucemyra To Treat Opioid Withdrawal

The National Institute on Drug Abuse says that more 115 people die daily from drug overdoses. There are a lot of lawsuits against opioid manufacturing companies and distributors as a result of the overdoses. More medications need to be made to help relieve those suffering from withdrawal symptoms so they can have a successful recovery.

More relapses are happening because when a drug addict is suffering from withdrawal, the symptoms can be so uncomfortable that you crave for more drugs to rid those symptoms. The symptoms can be experiencing stomach cramps, muscle aches, spasms, pounding heart, nausea, vomiting, diarrhea, anxiety, depression, agitation, and insomnia. There are medications to help with withdrawal symptoms like Buprenorphine but there are addictive side effects with that medication. Most patients manage their withdrawal symptoms by slowing weaning away from the dose to give the body a chance to adjust. Withdrawal is typically managed by the substitution of another opioid medication as well as the transition to maintenance therapy with FDA-approved medication-assisted treatment. There are also over-the-counter medications for upset stomach and aches or other treatments prescribed by their health care provider.

The FDA recently approved of Lucemyra which has helped treat opioid withdrawal in the U.K. for more than twenty years. Originally intended to be for hypertension, Lucemyra can reduce the release of norepinephrine which increases your heart rate and blood pressure. It is important to note that while this helps treat withdrawal symptoms, this medication does not act as the cure for addiction and should still do other treatment methods to follow.

Clinical trials have occurred with 866 adults that have opioid dependence. Participants were to rate their withdrawal symptom severity on a scale of one to thirty with thirty being the most severe. Those who were randomly assigned with this medication experienced less withdrawal symptoms compared to those who blindly took placebos. They were more likely to complete their treatment which lasted fourteen days. The side effects of Lucemyra are low blood sugar, slow heart rate, sleepiness, sedation, and dizziness. The FDA wants there to be fifteen more studies for children under age seventeen and for the treatment effects to last longer than fourteen days. Lucemyra should be available during the summer sold by U.S. WorldMeds. It is important for more medications to be available to treat withdrawal symptoms to decrease the risk of overdosing and increase the risk of recovery.

Located in Tacoma, Washington, Bayview Center’s mission is to offer clinically-driven programs and services to treat a number of substance abuse disorders along with anxiety and depression using cognitive behavioral therapy, dialectical behavioral therapy, trauma therapy, yoga therapy, and more for a successful recovery. For more information, please call us 888-570-7154 at as we are open 24 hours a day, 7 days a week.